Player Avatar TMFDeej (99.32) Submitted: 1/20/2013 9:54:24 PM : Outperform Start Price: $4.61 HBIO Score: +18.22

Harvard Bioscience is in the process of spinning off its money-losing HART division, leaving behind a manufacturer of scientific instruments trading for only three times earnings, yet growing at 15% to 20% per year.See Jim Royal's great article on the situation for more information:

Featured Broker Partners